From VFC's News, Notes & Weekly Stock Watch at VFC's NEW Stock House.
RPC: Speaking of TheStreet's biotech blog, it might be worth keeping an eye on shares of RPC this week.
Shares jumped 20% last week after trading resumed following an AMEX halt when TheStreet.com's biotech blog issued an emotionally-fueled hack job of a report on Radient Pharmaceuticals.
The biotech blog's heavily-biased view on the company was anything but objective, and the title of one of the cut-up blog posts was curiously changed, with no comments from TheStreet citing the reason why the title of the article was changed.
Of course, it's safe to assume that it was changed because it was misleading.
This story is anything but over, and is worth following even if it's only for entertainment value (See? Controversy sells.).
RPC shares closed down Friday by 10% and volatility is sure to play a part in the near term trading pattern.
Disclosure: No position.